ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 108 • 2023 Pediatric Rheumatology Symposium

    Development of Mental Health Guidance Statements for Pediatric Rheumatology

    Ashley Danguecan1, Natoshia Cunningham2, Samantha Ely3, Yaa Amponsah4, Alaina Davis5, Suzanne Edison6, Alicia Halbert4, Julia Harris7, Alicia Hoffman8, Jordan Jones7, Alana Leever9, Catherine Levalee4, Alison Manning10, Anne McHugh11, Sam Mendoza4, Crystal Mui4, Ekemini Ogbu12, Nikki Reitz4, Martha Rodriguez13, Natalie Rosenwasser14, Alyse Tankanow4, Erin Treemarcki15, Tracy Van Ness16, Katie Winner11, Tamar Rubinstein8 and Andrea Knight1, 1The Hospital for Sick Children, Toronto, ON, Canada, 2Michigan State University, Grand Rapids, MI, 3Michigan State University, East Lansing, 4CARRA Mental Health Taskforce, Washington, DC, 5Vanderbilt Children's Hospital, Nashville, TN, 6Cure JM Foundation, 7Children's Mercy, Kansas City, KS, 8Children's Hospital at Montefiore, New York, NY, 9Nationwide Children's Hospital, 10Duke University School of Medicine, Durham, NC, 11Dayton Children's Hospital, Dayton, OH, 12Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 13Riley Hospital for Children at Indiana University Health, Indianapolis, IN, 14Seattle Children's Hospital, Seattle, WA, 15University of Utah, Salt Lake City, UT, 16Pace University, New York, NY

    Background/Purpose: There are high rates of anxiety and depression in youth with rheumatologic diseases, with known impact on health-related outcomes. Thus, it is important to…
  • Abstract Number: 118 • 2023 Pediatric Rheumatology Symposium

    Serum Hepatocyte Growth Factor in Children with Juvenile Idiopathic Arthritis

    Natalia Shevchenko and Olga Pavlova, V. N. Karazin Kharkiv National University, Kharkiv, Ukraine

    Background/Purpose: Only limited data are available on the risk of liver fibrosis in patients with rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) on long-term…
  • Abstract Number: 121 • 2023 Pediatric Rheumatology Symposium

    The Effectiveness of Tonsillectomy in Periodic Fever, Aphthous Ulcer, Pharyngitis, and Adenitis Syndrome in Pediatric Patients

    John Storwick1 and Marinka Twilt2, 1Alberta Children's Hospital/University of Calgary, Calgary, AB, Canada, 2Alberta Children's Hospital, Calgary, AB, Canada

    Background/Purpose: Periodic Fevers with Aphthous Ulcers, Pharyngitis, and Adenitis Syndrome (PFAPA Syndrome) is the most common pediatric periodic fever syndrome. The most recent diagnostic criteria…
  • Abstract Number: 109 • 2023 Pediatric Rheumatology Symposium

    Long-term Safety of Biologics versus Conventional Synthetic Treatments in Systemic Juvenile Idiopathic Arthritis Patients

    Ana Isabel Rebollo-Giménez1, Luca Carlini2, Yulia Vyzhga3, Silvia Rosina4, Ekaterina Alexeeva5, Charlotte Myrup6, Silvia Magni Manzoni7, Maria Trachana8, Valda Stanevicha9, Constantin Ailioaie10, Elena Tsitsami11, Alexis-Virgil Cochino12, Chiara Pallotti13, Silvia Scala13, Angela Pistorio14, Sebastiaan Vastert15, Joost F. Swart16 and Nicolino Ruperto17, 1IRCCS Istituto Giannina Gaslini, UOC Reumatologia e Malattie Infiammatorie, Genova, Italy, 2IRCCS Istituto Giannina Gaslini, UOC Reumatologia e Malattie Autoinfiammatorie, Genova, Italy, 3IRCCS Istituto Giannina Gaslini, UOC Reumatologia e Malattia Infiammatorie, Genova, Italy, 4IRCCS Istituto Giannina Gaslini, Genova, Italy, 5Federal State Autonomous Institution “National Medical Research Center of Children's Health”, Ministry of Health of the Russian Federation, Moscow, Russia, 6Rigshospitalet, Pediatric rheumatology unit 4272, Copenhagem, Denmark, 7IRCCS Ospedale Pediatrico Bambino Gesù, Division of Rheumatology, Roma, Italy, 8Hippokration General Hospital, Thessaloniki University School of Medicine, First Department of pediatrics, Pediatric Immunology and Rheumatology Referral Center, Thessaloniki, Greece, 9Riga Stradins University, Children University Hospital, Riga, Latvia, 10Alexandru Ioan Cuza University of Iasi, Iasi, Romania, 11Aghia Sophia Childrens Hospital, First Department of Pediatrics, University of Athens Medical School, Athens, Greece, 12Institute for Mother and Child Care, Pediatrics, Bucharest, Romania, 13IRCCS Istituto Giannina Gaslini, U.O.C. Pediatric and Rheumatology Clinic, PRINTO, Genova, Italy, 14IRCCS Istituto Giannina Gaslini, Direzione Scientifica, Genova, Italy, 15Wilhelmina Children’s Hospital, Department of Pediatric Immunology and Rheumatology, Utrecht, The Netherlands, Utrecht, Netherlands, 16Wilhelmina Children’s Hospital, Department of Pediatric Immunology and Rheumatology, Utrecht, Netherlands, 17IRCCS Istituto Giannina Gaslini, UOSID Centro Trial, PRINTO, Genova, Italy

    Background/Purpose: The better understanding of systemic Juvenile Idiopathic Arthritis (sJIA) pathogenesis and availability of new drugs, such as biologic disease-modifying anti-rheumatic drugs (bDMARDs) specifically dedicated…
  • Abstract Number: 127 • 2023 Pediatric Rheumatology Symposium

    What’s in a Name? A20 Protein Expression in an in Vitro Model of A20 Haploinsufficiency

    Patricia Pontes Aires1, DANIELA GERENT PETRY PIOTTO1, Andre Cunha1, Sandro Perazzio2 and Maria Teresa Terreri3, 1Universidade Federal de São Paulo, São Paulo, Brazil, 2Universidade de So Paulo; Fleury Laboratories, São Paulo, Brazil, 3UNIFESP, São Paulo, Brazil

    Background/Purpose: Tumor necrosis factor alpha (TNF-alpha) induced protein 3 gene, or TNFAIP3, encodes the A20 protein, an important regulator of the NF-κB pathway. Since its…
  • Abstract Number: 114 • 2023 Pediatric Rheumatology Symposium

    Clinical Significance of SSA and SSB Antibodies in Pediatric SLE Patients: A Single Center Cohort

    Yiressy Pina1, Dawn Janysek1, Danielle Guffey2, Maria Pereira Palacios3 and Marietta De Guzman1, 1Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 2Baylor College of Medicine, Houston, TX, 3Baylor College of Medicine, Texas Children's Hospital, Houston, TX

    Background/Purpose: Anti-nuclear antibodies (ANA) are important in the diagnosis of Systemic Lupus Erythematosus (SLE). Of the disease specific ANAs, anti-dsDNA and anti- Smith antibodies carry…
  • Abstract Number: 094 • 2023 Pediatric Rheumatology Symposium

    Provider Assessment of the Temporomandibular Joint in Juvenile Idiopathic Arthritis

    Anna Costello1, Marinka Twilt2 and Melissa Lerman1, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2Alberta Children's Hospital, Calgary, AB, Canada

    Background/Purpose: TM joint arthritis is an underrecognized complication of JIA that can cause long-term problems including decreased mandibular growth, altered facial morphology, and orofacial pain.…
  • Abstract Number: 129 • 2023 Pediatric Rheumatology Symposium

    Interrogation of STAT3 Activation in Patients with Polyarticular Juvenile Arthritis (polyJIA)

    Stephanie Wood1, Justin Branch1, Priscilla vasquez1, Marietta De Guzman1, Amanda Brown2, A. Carmela Sagcal-Gironella3, Saimun Singla4, Andrea Ramirez5 and Tiphanie Vogel5, 1Baylor College of Medicine, Texas Children's Hospital, Houston, TX, 2University of Arkansas for Medical Sciences, Little Rock, AR, 3Hackensack University Medical Center, Hackensack, NJ, 4Self, Houston, TX, 5Baylor College of Medicine, Houston, TX

    Background/Purpose: A better understanding of the pathogenesis of polyJIA is necessary to guide more effective clinical care, such as the development of data-driven approaches to…
  • Abstract Number: 136 • 2023 Pediatric Rheumatology Symposium

    Incidence and Disease Burden of Juvenile Idiopathic Arthritis and Rheumatoid Arthritis After Non-Pharmaceutical Interventions in the COVID-19 Era: A Nationwide Observational Study in Korea

    Je Hee Shin1, Jung Yoon Pyo2, Minkyung Han3, Myeongjee Lee3, Sung Min Lim1, Jee Yeon Baek1, Ji Young Lee1, Ji-Man Kang1, InKyung Jung3 and Jong Gyun Ahn1, 1Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea, 2Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea, 3Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea

    Background/Purpose: Several countries have implemented non-pharmaceutical interventions (NPIs) against the coronavirus disease 2019 (COVID-19) pandemic. We investigated the impact of NPIs on the incidence of…
  • Abstract Number: 134 • 2023 Pediatric Rheumatology Symposium

    Patient-Provider Communication in Pediatric Rheumatology

    Julie Samuels, Emma Wojtal and Rebecca Trachtman, Icahn School of Medicine at Mount Sinai, New York, NY

    Background/Purpose: Communication is an essential part of medical care, especially in Pediatric Rheumatology where children have varying complex chronic diseases. However, there is paucity of…
  • Abstract Number: 100 • 2023 Pediatric Rheumatology Symposium

    The Brazilian Registry of Juvenile Dermatomyositis (JDM): II – A Longitudinal Assessment of Muscle Strength by Manual Muscle Test (MMT) and Childhood Myositis Assessment Scale (CMAS) Tools

    Darcisio Antonio1, Taciana Fernandes1, Adriana Elias2, Teresa Robazzi3, Ana Julia Moraes4, Sheila Oliveira5, Flavio Sztajnbok6, Luciana Carvalho7, Luciana Marques8, Silvana Sacchetti9, Maria Teresa Terreri10, Simone Appenzelle11, Roberto Marini12, Carlos Rabello Jr13, Cristina Magalhaes14, Melissa Fraga15, Marcia Bandeira16, Iloite Scheibel17, Isabela Daud2, Beatriz Carneiro2, Claudio Len18, Clovis Silva19 and Claudia Magalhaes20, 1Universidade Estadual Paulista (UNESP) Botucatu, Brazil, 2Instituto da Criança - Universidade de São Paulo (USP), São Paulo, Brazil, 3Universidade Federal da Bahia, Brazil, 4Universidade Federal do Para, Brazil, 5Universidade Federal do Rio de janeiro, Rio de Janeiro, 6Universidade Estadual do Rio de Janeiro, Rio de Janeiro, Brazil, 7Universidade de Sao Paulo- Ribeirao Preto, São Paulo, Brazil, 8Hospital Albert Sabin, Brazil, 9Santa Casa de Sao Paulo, Brazil, 10UNIFESP, São Paulo, Brazil, 11University of Campinas, Campinas, Sao Paulo, Brazil, 12UNICAMP, São Paulo, Brazil, 13Hospital Geral de Fortaleza, Brazil, 14Hospital Jose de Alencar - Brasilia, Brazil, 15Hospital Darcy Vargas, Brazil, 16Hospital Pequeno Principe- Curitiba, Brazil, 17Hospital Conceição de Porto Alegre, Brazil, 18Universidade Federal de São Paulo - Unifesp, São Paulo, Brazil, 19Universidade de São Paulo, São Paulo, Brazil, 20São Paulo State University, Pediatric Rheumatology Division, Botucatu, Brazil

    Background/Purpose: Muscle weakness is often progressive and persistent in Juvenile Dermatomyositis (JDM). Muscle strength testing is useful for evaluating severity of muscle weakness. There is…
  • Abstract Number: 123 • 2023 Pediatric Rheumatology Symposium

    Development of Specific Classification Criteria for Juvenile System Sclerosis Patients: A Scoping Review

    Ioana Dobre1, Suzanne Li2, Natalia Vasquez Canizares3, Barbara Reich4, Xurong Zhao5, Quinn McCormick6 and Marinka Twilt5, 1Alberta Children's Hospital/University of Calgary, Calgary, AB, Canada, 2Hackensack Meridian School of Medicine, Joseph M. Sanzari Children's Hospital, Hackensack, NJ, 3Children's Hospital at Montefiore, New York, NY, 4Hackensack University Medical Center, Hackensack, NJ, 5Alberta Children's Hospital, Calgary, AB, Canada, 6Hackensack Medical Hospital Network, Hackensack, NJ

    Background/Purpose: Juvenile systemic sclerosis (jSSc) is associated with one of the highest morbidity and mortality rate in pediatric rheumatology, yet care recommendations are based upon…
  • Abstract Number: 130 • 2023 Pediatric Rheumatology Symposium

    Levels of Neutrophil Extracellular Traps Correlate with Disease Activity in Pediatric Lupus

    Lydia Thomas1, Jenna Battaglia2, Bharati Matta3, Kim Simpfendorfer4, Joyce Hui-Yuen5 and Betsy Barnes3, 1Cohen Children's Medical Center, Northwell Health, New Hyde Park, NY, 2Northwell Health, New York, NY, 3Center for Autoimmune, Musculoskeletal, and Hematopoietic Diseases Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, 4Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, 5Cohen Children's Medical Center, Northwell Health, Lake Success, New York; Center for Autoimmune, Musculoskeletal, and Hematopoietic Diseases Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY

    Background/Purpose: Pediatric lupus (pSLE) is a multisystemic autoimmune disease characterized by autoantibody production leading to organ damage. Neutrophil extracellular traps (NETs) are considered a potential…
  • Abstract Number: 126 • 2023 Pediatric Rheumatology Symposium

    Facilitating Peer-to-Peer Conversations Around Key Clinical Trial Recruitment Barriers in the Limit-JIA Trial Using Low-Fidelity Video Capture

    Melanie Kohlheim1, Eveline Wu2, Laura Schanberg3, Vincent Del Gaizo1, Catherine Lavallee4, Marc Natter5, Katie Clem6, Brian Shakley6 and Kevin Urban7, 1CARRA, Washington, DC, 2UNC Chapel Hill, Chapel Hill, NC, 3Duke University Medical Center, Durham, NC, 4Virginia Tech Carilion School of Medicine, ROANOKE, VA, 5Boston Children's Hospital, Boston, MA, 6LIFT 1428, Llc, Ooltewah, TN, 7Business Coaching for Creatives, New York, NY

    Background/Purpose: The LIMIT-JIA trial aims to study if early abatacept treatment can prevent disease extension in children with recent-onset, uncomplicated, and oligoarticular or limited JIA.…
  • Abstract Number: 125 • 2023 Pediatric Rheumatology Symposium

    Measurable Outcomes of an Ophthalmology and Rheumatology Coordinated Care Clinic

    Catherine Lavallee1, Sabrina Gmuca2 and Melissa Lerman2, 1Virginia Tech Carilion School of Medicine, ROANOKE, VA, 2Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Non-infectious pediatric uveitis is a vision threatening disease whose treatment involves both ophthalmologists and rheumatologists.In other diseases necessitating multidisciplinary care, coordinated care clinics have…
  • « Previous Page
  • 1
  • …
  • 359
  • 360
  • 361
  • 362
  • 363
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology